This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Pattern recognition receptors in health and diseases
Signal Transduction and Targeted Therapy Open Access 04 August 2021
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
O'Neill LA, Golenbock D, Bowie AG . The history of Toll-like receptors-redefining innate immunity. Nat Rev Immunol 2013; 13: 453–460.
Takeuchi O, Akira S . Pattern recognition receptors and inflammation. Cell 2010; 140: 805–820.
Mantovani A, Garlanda C, Doni A, Bottazzi B . Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3. J Clin Immunol 2008; 28: 1–13.
Holmskov U, Thiel S, Jensenius JC . Collections and ficolins: humoral lectins of the innate immune defense. Annu Rev Immunol 2003; 21: 547–578.
Bottazzi B, Doni A, Garlanda C, Mantovani A . An integrated view of humoral innate immunity: pentraxins as a paradigm. Annu Rev Immunol 2010; 28: 157–183.
Henning LN, Azad AK, Parsa KV, Crowther JE, Tridandapani S, Schlesinger LS . Pulmonary surfactant protein A regulates TLR expression and activity in human macrophages. J Immunol 2008; 180: 7847–7858.
Ip WK, Takahashi K, Moore KJ, Stuart LM, Ezekowitz RA . Mannose-binding lectin enhances Toll-like receptors 2 and 6 signaling from the phagosome. J Exp Med 2008; 205: 169–181.
Liu H, Zhou J, Ma D, Lu X, Ming S, Shan G et al. Mannan binding lectin attenuates double-stranded RNA-mediated TLR3 activation and innate immunity. FEBS Lett 2014; 588: 866–872.
Mantovani A, Valentino S, Gentile S, Inforzato A, Bottazzi B, Garlanda C . The long pentraxin PTX3: a paradigm for humoral pattern recognition molecules. Ann NY Acad Sci 2013; 1285: 1–14.
Garlanda C, Bottazzi B, Bastone A, Mantovani A . Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol 2005; 23: 337–366.
Cieślik P, Hrycek A . Long pentraxin 3 (PTX3) in the light of its structure, mechanism of action and clinical implications. Autoimmunity 2012; 45: 119–128.
Sivick KE, Mobley HL . Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infect Immun 2010; 78: 568–585.
Jaillon S, Moalli F, Ragnarsdottir B, Bonavita E, Puthia M, Riva F et al. The humoral pattern recognition molecule PTX3 is a key component of innate immunity against urinary tract infection. Immunity 2014; 40: 621–632.
Mantovani A, Cassatella MA, Costantini C, Jaillon S . Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol 2011; 11: 519–531.
Lu J, Marnell LL, Marjon KD, Mold C, Du Clos TW, Sun PD . Structural recognition and functional activation of FcgammaR by innate pentraxins. Nature 2008; 456: 989–992.
Lech M, Römmele C, Kulkarni OP, Susanti HE, Migliorini A, Garlanda C et al. Lack of the long pentraxin PTX3 promotes autoimmune lung disease but not glomerulonephritis in murine systemic lupus erythematosus. PLoS One 2011; 6: e20118.
Norata GD, Garlanda C, Catapano AL . The long pentraxin PTX3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases. Trends Cardiovasc Med 2010; 20: 35–40.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhang, P., Liu, X. & Cao, X. Extracellular pattern recognition molecules in health and diseases. Cell Mol Immunol 12, 255–257 (2015). https://doi.org/10.1038/cmi.2014.81
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/cmi.2014.81
This article is cited by
-
Pattern Recognition Beyond the Surface: Soluble Pattern Recognition and Their Role in Periodontitis
Current Oral Health Reports (2022)
-
Pattern recognition receptors in health and diseases
Signal Transduction and Targeted Therapy (2021)